CPI-637 |
CPI-637 : Antagonist of EP300, CREBBP
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EP300 |
| |
| CREBBP |
|
|
Antagonist
up to 10 uM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - BRD9: 0.73 uM, BRD4: 11 uM
Potency Assay Off-Target:
In TR-FRET assays, CPI-637 was at least 700-fold selective for the targets over other Bromodomain pr ...
Selectivity Assessment Description:
In TR-FRET assays, CPI-637 was at least 700-fold selective for the targets over other Bromodomain pr ...
Potency Cellular
In Vitro
EP300
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acsmedchemlett.6b00075
CREBBP
Mode of Action: Antagonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acsmedchemlett.6b00075
Negative Control Compounds
enant-CPI-637: S)-4-methyl-6-(1-methyl-3-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-5-yl)-1,3,4,5-tetrahydro-2H-benzo[b][1,4]diazepin-2-one
Chemical Information
| Molecular Formula | C22H22N6O |
| SMILEs | C[C@@H]1CC(=O)Nc2cccc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2N1 |
| InChI | InChI=1S/C22H22N6O/c1-13-9-20(29)25-18-6-4-5-16(22(18)24-13)14-7-8-19-17(10-14)21(26-28(19)3)15-11-23-27(2)12-15/h4-8,10-13,24H,9H2,1-3H3,(H,25,29)/t13-/m1/s1 |
| Molecular weight | 386.19 Da |
| AlogP | 3.783400000000002 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 51 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.